This report studies the global market size of Gastrointestinal OTC Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastrointestinal OTC Drugs in these regions.
This research report categorizes the global Gastrointestinal OTC Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
In 2017, the global Gastrointestinal OTC Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Gastrointestinal OTC Drugs market based on company, product type, application and key regions.
The various contributors involved in the value chain of Gastrointestinal OTC Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Gastrointestinal OTC Drugs include
Bayer
GlaxoSmithKline
Johnson & Johnson
Pfizer
Perrigo
Abbott
C.B. Fleet
Purdue Pharma
Teva Pharmaceutical
Sanofi
Boehringer Ingelheim
Xiuzheng Pharmaceutical Group
China Resources Sanjiu Medical & Pharmaceutical
Harbin Pharmaceutical Group
JZJT
Tongrentang (TRT)
Market Size Split by Type
Capsule
Tablet
Others
Market Size Split by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Gastrointestinal OTC Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Gastrointestinal OTC Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gastrointestinal OTC Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gastrointestinal OTC Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Gastrointestinal OTC Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Gastrointestinal OTC Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gastrointestinal OTC Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Gastrointestinal OTC Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Tablet
1.4.4 Others
1.5 Market by Application
1.5.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal OTC Drugs Market Size
2.1.1 Global Gastrointestinal OTC Drugs Revenue 2016-2025
2.1.2 Global Gastrointestinal OTC Drugs Sales 2016-2025
2.2 Gastrointestinal OTC Drugs Growth Rate by Regions
2.2.1 Global Gastrointestinal OTC Drugs Sales by Regions
2.2.2 Global Gastrointestinal OTC Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Gastrointestinal OTC Drugs Sales by Manufacturers
3.1.1 Gastrointestinal OTC Drugs Sales by Manufacturers
3.1.2 Gastrointestinal OTC Drugs Sales Market Share by Manufacturers
3.1.3 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal OTC Drugs Revenue by Manufacturers
3.2.1 Gastrointestinal OTC Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Gastrointestinal OTC Drugs Price by Manufacturers
3.4 Gastrointestinal OTC Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal OTC Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Gastrointestinal OTC Drugs Sales by Type
4.2 Global Gastrointestinal OTC Drugs Revenue by Type
4.3 Gastrointestinal OTC Drugs Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Gastrointestinal OTC Drugs Breakdown Data by Application
6 North America
6.1 North America Gastrointestinal OTC Drugs by Countries
6.1.1 North America Gastrointestinal OTC Drugs Sales by Countries
6.1.2 North America Gastrointestinal OTC Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gastrointestinal OTC Drugs by Type
6.3 North America Gastrointestinal OTC Drugs by Application
6.4 North America Gastrointestinal OTC Drugs by Company
7 Europe
7.1 Europe Gastrointestinal OTC Drugs by Countries
7.1.1 Europe Gastrointestinal OTC Drugs Sales by Countries
7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal OTC Drugs by Type
7.3 Europe Gastrointestinal OTC Drugs by Application
7.4 Europe Gastrointestinal OTC Drugs by Company
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal OTC Drugs by Countries
8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Countries
8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gastrointestinal OTC Drugs by Type
8.3 Asia Pacific Gastrointestinal OTC Drugs by Application
8.4 Asia Pacific Gastrointestinal OTC Drugs by Company
9 Central & South America
9.1 Central & South America Gastrointestinal OTC Drugs by Countries
9.1.1 Central & South America Gastrointestinal OTC Drugs Sales by Countries
9.1.2 Central & South America Gastrointestinal OTC Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gastrointestinal OTC Drugs by Type
9.3 Central & South America Gastrointestinal OTC Drugs by Application
9.4 Central & South America Gastrointestinal OTC Drugs by Company
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal OTC Drugs by Countries
10.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Countries
10.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gastrointestinal OTC Drugs by Type
10.3 Middle East and Africa Gastrointestinal OTC Drugs by Application
10.4 Middle East and Africa Gastrointestinal OTC Drugs by Company
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.1.4 Gastrointestinal OTC Drugs Product Description
11.1.5 Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.2.4 Gastrointestinal OTC Drugs Product Description
11.2.5 Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.3.4 Gastrointestinal OTC Drugs Product Description
11.3.5 Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.4.4 Gastrointestinal OTC Drugs Product Description
11.4.5 Recent Development
11.5 Perrigo
11.5.1 Perrigo Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.5.4 Gastrointestinal OTC Drugs Product Description
11.5.5 Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.6.4 Gastrointestinal OTC Drugs Product Description
11.6.5 Recent Development
11.7 C.B. Fleet
11.7.1 C.B. Fleet Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.7.4 Gastrointestinal OTC Drugs Product Description
11.7.5 Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.8.4 Gastrointestinal OTC Drugs Product Description
11.8.5 Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.9.4 Gastrointestinal OTC Drugs Product Description
11.9.5 Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Gastrointestinal OTC Drugs
11.10.4 Gastrointestinal OTC Drugs Product Description
11.10.5 Recent Development
11.11 Boehringer Ingelheim
11.12 Xiuzheng Pharmaceutical Group
11.13 China Resources Sanjiu Medical & Pharmaceutical
11.14 Harbin Pharmaceutical Group
11.15 JZJT
11.16 Tongrentang (TRT)
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Gastrointestinal OTC Drugs Raw Material
13.1.2 Gastrointestinal OTC Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Gastrointestinal OTC Drugs
Figure Global Gastrointestinal OTC Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Gastrointestinal OTC Drugs Production Market Share by Types (Product Category) in 2017
Figure Capsule Product Picture
Table Major Manufacturers of Capsule
Figure Tablet Product Picture
Table Major Manufacturers of Tablet
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Hospital Pharmacy
Figure Retail Pharmacy
Figure Online Pharmacy
Figure Gastrointestinal OTC Drugs Report Years Considered
Figure Global Gastrointestinal OTC Drugs Market Size 2016-2025 (Million US$)
Figure Global Gastrointestinal OTC Drugs Sales 2016-2025 (K Pcs)
Table Global Gastrointestinal OTC Drugs Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Gastrointestinal OTC Drugs Sales by Regions 2016-2025 (K Pcs)
Table Global Gastrointestinal OTC Drugs Sales Market Share by Regions 2016-2025
Figure Global Gastrointestinal OTC Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Gastrointestinal OTC Drugs Sales Market Share by Regions
Table Global Gastrointestinal OTC Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Gastrointestinal OTC Drugs Revenue Market Share by Regions 2016-2025
Figure Global Gastrointestinal OTC Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Gastrointestinal OTC Drugs Revenue Market Share by Regions
Table Global Gastrointestinal OTC Drugs Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Gastrointestinal OTC Drugs Sales Share by Manufacturers in 2017
Table Gastrointestinal OTC Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2016-2018)
Figure Gastrointestinal OTC Drugs Value Share by Manufacturers in 2017
Table Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Gastrointestinal OTC Drugs Price (2016-2018) (USD/Pcs)
Table Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gastrointestinal OTC Drugs Product Category
Table Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal OTC Drugs Sales by Type (2016-2025) (K Pcs)
Table Global Gastrointestinal OTC Drugs Sales Share by Type (2016-2025)
Figure Global Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2025)
Figure Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2017
Table Global Gastrointestinal OTC Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Gastrointestinal OTC Drugs Revenue Share by Type (2016-2025)
Figure Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2016-2025)
Figure Global Gastrointestinal OTC Drugs Revenue Market Share by Type in 2017
Table Gastrointestinal OTC Drugs Price by Type 2013-2018 (USD/Pcs)
Table Global Gastrointestinal OTC Drugs Sales by Application (2016-2025) (K Pcs)
Table Global Gastrointestinal OTC Drugs Sales Share by Application (2016-2025)
Figure Global Sales Gastrointestinal OTC Drugs Market Share by Application (2016-2025)
Figure Global Sales Gastrointestinal OTC Drugs Market Share by Application (2016-2025)
Figure North America Gastrointestinal OTC Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Gastrointestinal OTC Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Gastrointestinal OTC Drugs Sales by Countries (2016-2025) (K Pcs)
Table North America Gastrointestinal OTC Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Gastrointestinal OTC Drugs Sales Market Share by Countries
Table North America Gastrointestinal OTC Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Gastrointestinal OTC Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Gastrointestinal OTC Drugs Revenue Market Share by Countries
Figure United States Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Gastrointestinal OTC Drugs Sales by Type (2016-2025) (K Pcs)
Table North America Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Gastrointestinal OTC Drugs Market Share by Type
Table North America Gastrointestinal OTC Drugs Sales by Application (2016-2025) (K Pcs)
Table North America Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Gastrointestinal OTC Drugs Market Share by Application
Table North America Gastrointestinal OTC Drugs Sales by Company (2016-2018) (K Pcs)
Table North America Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2018)
Figure North America Gastrointestinal OTC Drugs Sales Market Share by Company in 2017
Figure Europe Gastrointestinal OTC Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Gastrointestinal OTC Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Gastrointestinal OTC Drugs Sales by Countries (2016-2025) (K Pcs)
Table Europe Gastrointestinal OTC Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Gastrointestinal OTC Drugs Sales Market Share by Countries
Table Europe Gastrointestinal OTC Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Gastrointestinal OTC Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Gastrointestinal OTC Drugs Revenue Market Share by Countries
Figure Germany Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure France Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Gastrointestinal OTC Drugs Sales by Type (2016-2025) (K Pcs)
Table Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Gastrointestinal OTC Drugs Market Share by Type
Table Europe Gastrointestinal OTC Drugs Sales by Application (2016-2025) (K Pcs)
Table Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Gastrointestinal OTC Drugs Market Share by Application
Table Europe Gastrointestinal OTC Drugs Sales by Company (2016-2018) (K Pcs)
Table Europe Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2018)
Figure Europe Gastrointestinal OTC Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Gastrointestinal OTC Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Gastrointestinal OTC Drugs Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Countries
Table Asia Pacific Gastrointestinal OTC Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Countries
Figure China Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure China Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure India Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal OTC Drugs Market Share by Type
Table Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal OTC Drugs Market Share by Application
Table Asia Pacific Gastrointestinal OTC Drugs Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Company in 2017
Figure Central & South America Gastrointestinal OTC Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Gastrointestinal OTC Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Gastrointestinal OTC Drugs Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Gastrointestinal OTC Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Gastrointestinal OTC Drugs Sales Market Share by Countries
Table Central & South America Gastrointestinal OTC Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Gastrointestinal OTC Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Gastrointestinal OTC Drugs Revenue Market Share by Countries
Figure Brazil Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Gastrointestinal OTC Drugs Sales by Type (2016-2025) (K Pcs)
Table Central & South America Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Gastrointestinal OTC Drugs Market Share by Type
Table Central & South America Gastrointestinal OTC Drugs Sales by Application (2016-2025) (K Pcs)
Table Central & South America Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Gastrointestinal OTC Drugs Market Share by Application
Table Central & South America Gastrointestinal OTC Drugs Sales by Company (2016-2018) (K Pcs)
Table Central & South America Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Gastrointestinal OTC Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Gastrointestinal OTC Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Gastrointestinal OTC Drugs Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Countries
Table Middle East and Africa Gastrointestinal OTC Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries
Figure GCC Countries Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Gastrointestinal OTC Drugs Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Gastrointestinal OTC Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal OTC Drugs Market Share by Type
Table Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal OTC Drugs Market Share by Application
Table Middle East and Africa Gastrointestinal OTC Drugs Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Company in 2017
Table Bayer Company Details
Table Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Bayer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Perrigo Company Details
Table Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Perrigo Recent Development
Table Abbott Company Details
Table Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Abbott Recent Development
Table C.B. Fleet Company Details
Table C.B. Fleet Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table C.B. Fleet Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Purdue Pharma Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Teva Pharmaceutical Recent Development
Table Sanofi Company Details
Table Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Boehringer Ingelheim Company Details
Table Xiuzheng Pharmaceutical Group Company Details
Table China Resources Sanjiu Medical & Pharmaceutical Company Details
Table Harbin Pharmaceutical Group Company Details
Table JZJT Company Details
Table Tongrentang (TRT) Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Gastrointestinal OTC Drugs Value Chain
Table Typical Suppliers of Key Gastrointestinal OTC Drugs Raw Material
Table Gastrointestinal OTC Drugs Customers List
Table Gastrointestinal OTC Drugs Sales Channels
Table Gastrointestinal OTC Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
